Execs On The Move In May 2022: Boston Scientific Changes Board; Butterfly Shakes Up Leadership Team
An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.
You may also be interested in...
Liquid biopsy represents potential advantages over traditional approaches to cancer surveillance, treatment selection and recurrence monitoring. But one size does not fit all, requiring tailored solutions for less developed markets.
The company has enrolled the first patient in the second human trial of its implantable metabolite monitoring system, which it expects could change the game for blood glucose measurement.
Start-up Esper Bionics has designed a prosthetic hand that can anticipate a user’s actions, changing the game for amputees.